What should cardiologists be telling general practitioners/family physicians? by Hobbs, R

How well are we doing in lipid management? by Hobbs, R

Near patient testing in primary care. by Hobbs, R

It's come a long way. by Hobbs, R

In British Asian hypertensive patients, doxazosin provides greater improvement in glycemic control and lipid profile than bendrofluazide by Hobbs, R

Response to the national service framework on coronary heart disease: Is it sufficiently evidence-based? by Hobbs, R

Evaluating the safety of drugs by Hobbs, R

Identification and treatment of patients with atrial fibrillation in primary care. by Hobbs, R

MANAGING VIOLENCE IN THE PRACTICE by Hobbs, R

Management of global risk in primary care by Hobbs, R

The National Service Framework for Coronary Heart Disease by Hobbs, R

Epccs: European primary care cardiovascular society. by Hobbs, R

Dietary fat and heart disease: The view from general practice by Hobbs, R

General practitioners' changes to practice due to aggression at work. by Hobbs, R

Guidelines and management of global risk: the European perspective by Hobbs, R

Challenges of anticoagulant therapy in patients with atrial fibrillation in clinical practice. by Hobbs, R

Is the calcium antagonist debate having an effect on clinical practice? by Hobbs, R

Can we do more to get patients to cholesterol targets? by Hobbs, R

TRANSLATING GUIDELINES INTO INTERVENTION by Hobbs, R

Fear of aggression at work among general practitioners who have suffered a previous episode of aggression. by Hobbs, R